Investigation on the Therapeutic Mechanism of Danbie Capsules for Endometriosis: A Network Pharmacology Approach
DOI: https://doi.org/10.2147/ijgm.s451119
IF: 2.145
2024-06-04
International Journal of General Medicine
Abstract:Lina Zhang, 1– 3, &ast Ruibin Wu, 2, 3, &ast Tenghui Ma, 2, 3 Wenwen Fu, 2, 3 Jiamin Chen, 2, 3 Lingling Li, 2, 3 Qing He 2, 3 1 The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510080, People's Republic of China; 2 Department of Clinical Nutrition and Microbiome; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, People's Republic of China; 3 Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qing He, Email Objective: To explore the active substances and targets of Danbie Capsules in Endometriosis therapy. Methods: This study was conducted through TCMSP and published literature screened and obtained 183 active substances of Danbie Capsules, combined and intersected with Endometriosis target genes collected and screened in the GEO database, obtained 24 target genes for Endometriosis treatment, and mapped the target network map of Danbie Capsules active substances against Endometriosis. The network was analyzed with the aid of Cytoscape version 3.9.1. With the aid of the platform of the STRING data analysis, PPI network analysis was conducted on 24 anti-Endometriosis targets of the Danbie Capsules. Results: The research results obtained three critical active substances, namely, Quercetin, β-sitosterol, and Luteolin. Seven critical targets were identified, and two representative genes (TP53 and AKT1) have been verified in Macromolecular docking and immunohistochemical verification. Conclusion: The active substances of Danbie Capsules in the treatment of Endometriosis are Quercetin, β-sitosterol and Luteolin, and the main targets are TP53 and AKT1. Keywords: danbie capsules, endometriosis, network pharmacology Endometriosis, as a chronic inflammatory disorder characterized by the ectopic localization of endometrial tissue outside the uterine cavity, can result in pelvic pain and infertility. This condition represents a substantial public health burden due to its profound influence on the quality of life of the affected women. 1 Endometriosis is recognized as one of the prevalent benign gynecological proliferative disorders among premenopausal women, with an estimated prevalence of 10–15% among women of childbearing potential. The exact biological mechanisms underlying endometriosis remain not fully understood. Despite being a prevalent disorder, the pathophysiology of endometriosis remains elusive. Furthermore, recent studies have suggested a lack of association between the severity of the disease and the manifestation of symptoms. Currently, there is a lack of widely used blood-based diagnostic tests specifically designed for endometriosis. Moreover, no universally effective treatment approach can guarantee the complete resolution of the condition. Endometriosis belongs to the "sticking mass" category in Traditional Chinese medicine. Traditional Chinese medicine believes that this disease is caused by the stagnation of qi and blood stasis and the stagnation of blood stasis. Danbie Capsules are composed of 12 drugs, including Herba Scutellariae Barbatae, Radix Notoginseng, Rhizoma Sparganii, Rhizoma Curcumae, Semen Persicae, Radix Angelicae Sinensis, Turtle Carapace, Seaweed, Largehead Atractylodes Rhizome, Cortex Eucommiae, Herba Scutellariae Barbatae, and Ramulus Cinnamomi. The combination of various drugs aims to promote blood circulation, dissipate blood stasis, and soften and disperse nodules. Hu Sisi et al found that Danbie Capsules can reduce the concentration of PGE2 and TNF- α in the blood of EMs rats, which may be one of the effective mechanisms for its treatment of endometriosis. 2 Liu Zhenming et al research showed that Danbie Capsules have a certain therapeutic effect on Endometriosis. According to the influence on cytokines and grafts, the Active substance in the prescription is separated, and its action target and specific action mechanism are studied according to the active substance. 3 Zhang Chunhong et al found that Danbie Capsules can exhibit inhibitory effects on the proliferation of ectopic endometrial tissue. This effect was attributed to the reduction in the levels of prostaglandin E2 (PGE-2) and tumor necrosis factor (TNF) in both the serum and peritoneal fluid of the experimental rat models. The anti-inflammation, analgesia, improvement of blood rheology and microcirculation, and other functions are very crucial in the treatm -Abstract Truncated-
medicine, general & internal